677 related articles for article (PubMed ID: 28218671)
21. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
22. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
23. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1.
Miethke T; Duschek K; Wahl C; Heeg K; Wagner H
Eur J Immunol; 1993 Jul; 23(7):1494-500. PubMed ID: 8325325
[TBL] [Abstract][Full Text] [Related]
25. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
26. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
[TBL] [Abstract][Full Text] [Related]
27. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
28. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
29. Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1.
Shimonkevitz R; Boen E; Malmstrom S; Brown E; Hurley JM; Kotzin BL; Matsumura M
Infect Immun; 1996 Apr; 64(4):1133-9. PubMed ID: 8606069
[TBL] [Abstract][Full Text] [Related]
30. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
Narita K; Hu DL; Asano K; Nakane A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
[TBL] [Abstract][Full Text] [Related]
32. [Neutralizing activity of human immunoglobulin preparation against toxic shock syndrome toxin-1].
Nakae T; Hirayama F; Hashimoto M
Kansenshogaku Zasshi; 2002 Mar; 76(3):195-202. PubMed ID: 11974889
[TBL] [Abstract][Full Text] [Related]
33. Modeling of receptor mimics that inhibit superantigen pathogenesis.
Möllhoff M; Zanden HB; Shiflett PR; Gupta G
J Mol Recognit; 2005; 18(1):73-83. PubMed ID: 15459942
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
Pang LT; Kum WW; Chow AW
Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
[TBL] [Abstract][Full Text] [Related]
35. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
Hofer MF; Lester MR; Schlievert PM; Leung DY
Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
[TBL] [Abstract][Full Text] [Related]
37. Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1.
Rubinchik E; Chow AW
Vaccine; 2000 Apr; 18(21):2312-20. PubMed ID: 10717352
[TBL] [Abstract][Full Text] [Related]
38. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
Dennig D; O'Reilly RJ
J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
[TBL] [Abstract][Full Text] [Related]
39. Human peripheral gammadelta T cells potentiate the early proinflammatory cytokine response to staphylococcal toxic shock syndrome toxin-1.
Kalyan S; Chow AW
J Infect Dis; 2004 May; 189(10):1892-6. PubMed ID: 15122526
[TBL] [Abstract][Full Text] [Related]
40. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
